Rchr
J-GLOBAL ID:201801008704195507   Update date: Oct. 02, 2024

Kaizaki-Mitsumoto Asuka

ミツモト アスカ | Kaizaki-Mitsumoto Asuka
Affiliation and department:
Research field  (1): Pharmaceuticals - health and biochemistry
Research keywords  (3): 毒性学 ,  中毒 ,  乱用薬物
Research theme for competitive and other funds  (6):
  • 2023 - 2026 ADHD 治療薬の DOHaD 影響-エピジェネティクス作用と発達障害-
  • 2019 - 2022 司法への貢献を目指した覚せい剤受動喫煙に関する研究
  • 2015 - 2018 Molecular mechanism underlying pathophysiological insulin secretion during early type 2 diabetes mellitus.
  • 2015 - 2017 乱用実態に即した危険ドラッグやその不純物毒性の総合的評価
  • 2013 - 2015 乱用薬の市場変化に対応する新規薬物スクリーニング法の開発と応用
Show all
Papers (50):
  • Yoshitaka Yamazaki, Asuka Kaizaki-Mitsumoto, Mariko Sato, Yumiko Inoue, Kazuyuki Miyamoto, Keisuke Suzuki, Munetaka Hayashi, Kenji Dohi, Satoshi Numazawa. Simultaneous analysis of caffeine and paraxanthine provides potentially useful indexes in the treatment of acute caffeine intoxication. The Journal of Toxicological Sciences. 2024. 49. 10. 447-457
  • Sakiko Munetomo-Aoki, Asuka Kaizaki-Mitsumoto, Ryota Nakano, Satoshi Numazawa. Paternal methamphetamine exposure differentially affects first and second generations in mice. The Journal of Toxicological Sciences. 2024. 49. 1. 9-26
  • Hirozumi Okuda, Hidetada Fukushima, Tomoaki Nakatsukasa, Koji Yamamoto, Asuka Kaizaki-Mitsumoto, Satoshi Numazawa, Yoshito Kamijo. Fatal poisoning due to ingestion of boiled oleander leaf extract. Journal of Forensic Sciences. 2023
  • Haruka Morinaka, Asuka Kaizaki-Mitsumoto, Hokuto Morohoshi, Naoki Uchida, Satoshi Numazawa. Urinary profiles of methoxyphenamine and its metabolite after inhalation of methoxyphenamine smoke in humans: aiming to distinguish between active and passive exposure. Forensic toxicology. 2023. 41. 2. 230-240
  • Kota Nakajima, Asuka Kaizaki-Mitsumoto, Satoshi Numazawa. Flunitrazepam alters the toxicokinetics of chlorpromazine enhancing its toxicity. Fundamental Toxicological Sciences. 2023. 10. 8. 315-323
more...
MISC (13):
  • 森中遥香, 光本(貝崎)明日香, 諸星北人, 諸星北人, 内田直樹, 沼澤聡. Urinary concentration changes in human after passive or active inhalation of methoxyphenamine smoke, a model drug for methamphetamine. 日本薬学会年会要旨集(Web). 2023. 143rd
  • 阿部 和正, 光本 明日香[貝崎], 青木 悟, 齋藤 友広, 杉山 元紀, 二村 哲未, 上嶋 和代, 佐々木 忠徳, 沼澤 聡. アシクロビル脳症疑い例におけるアシクロビルおよび代謝物の血中濃度測定. 中毒研究. 2020. 33. 2. 170-170
  • Keisuke Suzuki, Kazuyuki Miyamoto, Asuka Kaizaki-Mitsumoto, Satoshi Numazawa, Gen Inoue, Akihito Katoh, Kenji Dohi. SERIOUS DIPHENHYDRAMINE OVERDOSE IN WHICH BLOOD LEVEL WAS MEASURED DURING HEMODIALYSIS. CRITICAL CARE MEDICINE. 2020. 48
  • 宮本和幸, 宮本和幸, 光本(貝崎)明日香, 井上元, 井上元, 佐藤真理子, 佐藤真理子, 高安弘美, 高安弘美, 大野孝則, et al. 急性カフェイン中毒7例の検討. 日本集中治療医学会学術集会(Web). 2019. 46th. Suppl. [O44-2]
  • HATTORI Natsumi, MORINAKA Haruka, KAIZAKI-MITSUMOTO Asuka, NUMAZAWA Satoshi. Proposed novel mechanism of adverse reaction elicited by atypical antipsychotic olanzapine. Annual Meeting of the Japanese Society of Toxicology. 2018. 45. 0. P-180
more...
Education (2):
  • 2003 - 2005 Showa University Guraduate School of Pharmaceutical Sciences
  • 1999 - 2003 Showa University School of Pharmacy Division of Biopharmacology
Professional career (1):
  • 博士(薬学)
Work history (7):
  • 2024/08 - 現在 Showa University School of Pharmacy Division of Toxicology Associate Professor
  • 2017/12 - 2024/08 Showa University Toxicology, School of Pharmacy
  • 2019/07 - 2020/03 Ministry of Education,Culture,Sports,Science and Technology
  • 2018/04 - 2019/03 Ministry of Education,Culture,Sports,Science and Technology
  • 2012/04 - 2017/11 Showa University Toxicology, School of Pharmacy
Show all
Committee career (3):
  • 2021/04 - 現在 Japanese Society of Clinical and Analytical Toxicology (J’s-CAT) Councilor
  • 2019/07 - 現在 日本法中毒学会 評議員
  • 2019/01 - 現在 日本法中毒学会 若手研究者委員
Awards (1):
  • 2017/07 - 日本毒性学会 ファイザー賞
Association Membership(s) (4):
THE JAPANESE SOCIETY OF TOXICOLOGY ,  JAPANESE ASSOCIATION OF FORENSIC TOXICOLOGY ,  THE PHARMACEUTICAL SOCIETY OF JAPAN ,  日本臨床・分析中毒学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page